Skip to main content
Clinical Trials/NCT01491334
NCT01491334
Completed
Not Applicable

A Clinical Validation Study With Transvaginal Tactile Imaging

Artann Laboratories2 sites in 1 country158 target enrollmentDecember 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pelvic Organ Prolapse
Sponsor
Artann Laboratories
Enrollment
158
Locations
2
Primary Endpoint
Effectiveness in assessment of the pelvic floor tissue conditions.
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to validate safety and effectiveness in assessment of the female pelvic floor tissue, and, assess the ability of Vaginal Tactile Imager (VTI) to detect early prolapse conditions and characterize the outcome of reconstructive surgery.

Detailed Description

1. The device will detect significant differences in tissue elasticity and anatomy for women with normal pelvic floor versus women with prolapse stage 1. 2. The device will detect significant differences in tissue elasticity and anatomy for patients before and after reconstructive surgery. 3. The device will detect significant differences in tissue elasticity and anatomy among 3 groups of patients with prolapse stages 1, 2 and 3. 4. The device will detect significant differences in tissue elasticity among 3 control groups with normal pelvic floor conditions (nulliparous women at age 21-30, parous women at age 31-40, and postmenopausal women).

Registry
clinicaltrials.gov
Start Date
December 2011
End Date
November 2013
Last Updated
12 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Artann Laboratories
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject is female of 21 years or older AND HAS AT LEAST ONE OF THE FOLLOWING
  • No evidence of pelvic organ prolapse and no prior pelvic surgery
  • Stage 1 or greater pelvic organ prolapse affecting one or more vaginal compartments and no prior pelvic surgery
  • Stage 2 or greater pelvic organ prolapse affecting one or more vaginal compartments and reconstructive surgery is scheduled

Exclusion Criteria

  • Active skin infection or ulceration within the vagina
  • Presence of a vaginal septum;
  • Active cancer of the colon, rectum wall, cervix, vaginal, uterus or bladder;
  • Ongoing radiation therapy for pelvic cancer;
  • Impacted stool
  • Recent (less than three months) pelvic surgery;
  • Significant pre-existing pelvic pain including levator ani syndrome, severe vaginismus or vulvodynia;
  • Severe hemorrhoids
  • Surgically absent rectum or bladder
  • Significant circulatory or cardiac conditions that could cause excessive risk from the examination as determined by attending physician

Outcomes

Primary Outcomes

Effectiveness in assessment of the pelvic floor tissue conditions.

Time Frame: Two years.

Ability in early detection of prolapse conditions.

Time Frame: One Year

Ability in characterization of the outcome of pelvic floor reconstructive surgery.

Time Frame: Two years.

Study Sites (2)

Loading locations...

Similar Trials